Cover Image

The brain strikes back: Hypothalamic targets for peripheral CB1 receptor inverse agonism

Saved in:

Bibliographic Details
Main Author:	Daniela Cota (Author)
Format:	Book
Published:	Elsevier, 2017-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

mTORC1 and CB1 receptor signaling regulate excitatory glutamatergic inputs onto the hypothalamic paraventricular nucleus in response to energy availability
by: Wilfrid Mazier, et al.
Published: (2019)

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018)

Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling
by: Joseph Tam, et al.
Published: (2017)

2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties
by: Daniela R. de Oliveira, et al.
Published: (2022)

Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
by: Michelle Roche, et al.
Published: (2010)

Beta-Blockers Show Inverse Agonism to a Novel Constitutively Active Mutant of β1-Adrenoceptor
by: Maruf Ahmed, et al.
Published: (2006)

BIASED AGONISM OF THREE DIFFERENT CANNABINOID RECEPTOR AGONISTS IN MOUSE BRAIN CORTEX
by: Rebeca Diez-Alarcia, et al.
Published: (2016)

Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome
by: Ibrahim Knani, et al.
Published: (2016)

Voltage dependence of the cannabinoid CB1 receptor
by: Esty Goldberger, et al.
Published: (2022)

Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
by: Ken Soderstrom, et al.
Published: (2017)

Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Experimental Colitis
by: Sonia Kiran, et al.
Published: (2022)

The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice
by: Francisco J. Bermudez-Silva, et al.
Published: (2016)

Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine
by: Rodríguez-Muñoz María, et al.
Published: (2009)

Harnessing MerTK agonism for targeted therapeutics
by: Vivekananda Kedage, et al.
Published: (2020)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019)

Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1
by: Emanuele Criscuolo, et al.
Published: (2023)

Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors
by: Shayma El-Atawneh, et al.
Published: (2022)

CB2 and GPR55 receptors as therapeutic targets for systemic immune dysregulation
by: Juan Zhou, et al.
Published: (2016)

CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin
by: Pierre Cardinal, et al.
Published: (2014)

Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
by: Jonathan E. Campbell
Published: (2021)

The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells
by: Haddad M
Published: (2021)

5-HT6 receptor agonism facilitates emotional learning
by: Marcela ePereira, et al.
Published: (2015)

GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
by: Tito Borner, et al.
Published: (2023)

Targeted IgMs agonize ocular targets with extended vitreal exposure
by: Yvonne Chen, et al.
Published: (2020)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
by: Katrine D. Galsgaard, et al.
Published: (2022)

Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation
by: Alessia Costa, et al.
Published: (2022)

GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
by: Jennifer Taher, et al.
Published: (2014)

The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein Interactions
by: Rafael Franco, et al.
Published: (2021)

Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice
by: Haiming Ma, et al.
Published: (2018)

Expression and Functions of the CB2 Receptor in Human Leukocytes
by: Mélissa Simard, et al.
Published: (2022)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
by: Reem Smoum, et al.
Published: (2022)

Transcriptomic Profiling in Mice With CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain
by: Yongmin Liu, et al.
Published: (2022)

The interaction of Suk-Saiyasna remedy with GABAA and CB1 receptor-targeting drugs: Enhancing hypnotic and sedative effects in in vivo models
by: Watchara Damjuti, et al.
Published: (2024)

Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent
by: Shahar Azar, et al.
Published: (2020)

Histamine 2 Receptor Agonism and Histamine 4 Receptor Antagonism Ameliorate Inflammation in a Model of Psoriasis
by: Kristine Rossbach, et al.
Published: (2020)

Effects of 12 weeks of barefoot running on foot strike patterns, inversion-eversion and foot rotation in long-distance runners
by: Pedro A. Latorre-Román, et al.
Published: (2019)

Athletics, Gymnastics, and Agon in Plato
by: Reid, Heather L.
Published: (2020)

Effects of the peripheral CB1 receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
by: Patryk Remiszewski, et al.
Published: (2022)

On the role of cannabinoid CB1- and µ-opioid receptors in nicotine-induced motor impulsivity
by: Joost eWiskerke, et al.
Published: (2012)

Association of cannabis use during adolescence, prefrontal CB1 receptor signaling and schizophrenia
by: Adriana eCaballero, et al.
Published: (2012)